macro-eyes product Sibyl is AI for intelligent patient scheduling and has demonstrated the ability to increase utilization by 15%, allowing providers to see more patients without adding clinical hours to their day. macro-eyes technology is the result of years of refining and deploying core AI for clinical decision support at Stanford, a leading academic medical center in NYC and at one of the largest health systems in the United States.
The Bill & Melinda Gates Foundation is funding macro-eyes to implement the predictive supply chain for health (first major investment by the foundation in AI for global health): technology to predict consumption levels and decipher demand at the level of individual health facilities and pharmacies and recommend levels and selection to eliminate stock-outs, cut wastage, and increase access to life-saving care. macro-eyes is partnering with the California Primary Care Association to bring SIBYL (software for predicting and perfecting utilization) to 1,800 health facilities.
Total Funding: $2,700,000
Funding Stage: Funded
Business Stage: Scaling Up
Market: B2B
Company Size: 26 to 50
Founded: 2014
Machine Learning Scientist
Seattle, Washington
Software Engineer
Seattle, Washington
Android Engineer
Seattle, Washington
Director of Communications
Seattle, Washington
